Connect Biopharma Holdings Limited's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Connect Biopharma Holdings Limited's ROA in the second quarter of 2026?
Connect Biopharma Holdings Limited recorded a cumulative net loss of $-69 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -169.78%.

However, within the Healthcare sector 871 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4561, from total ROA ranking in the first quarter of 2026 at 5238.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	2.68 %	-66.47 %	-33.18 %	192.81 %	-86.31 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-69	-65	-55	-56	-52
Return On Assets (TTM)	-169.78 %	-160.11 %	-114.37 %	-100.95 %	-108.08 %
CNTB's Total Ranking	# 4561	# 5238	# 4545	# 4587	# 3972
Total Assets (TTM) in million	43	16	56	47	42
Seq. Total Assets Change	164.11 %	-70.65 %	20.51 %	9.91 %	-13.76 %
Seq. Net Income Change	-	-	-	-	-

CNTB's 5 Years Annual ROA >> Back to CNTB Management Effectiveness >> Compare CNTB ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 416
Sector	# 872
Overall	# 4475

Return On Assets Statistics
High	Average	Low
-24.09 %	-126.86 %	-301.22 %
(Dec 31 2024)		(Mar 31 2026)

Financial Statements
Connect Biopharma Holdings Limited's Assets	$ 43 million	CNTB's Balance sheet
Connect Biopharma Holdings Limited's Income	$ -17 million	Quarterly CNTB's Income Statement
CNTB's Income by Division		See CNTB's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	-40.48 %	-64.17 %	47.24 %	-43.47 %	-
Total Assets in million	50	85	237	161	285
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-55	-16	-60	-118	-202
Annual Return On Assets	-109.87 %	-18.42 %	-25.13 %	-73.43 %	-71.09 %

CNTB's 5 Years Annual ROA >> Back to CNTB Management Effectiveness >> Compare CNTB ROA to its Competitors

More Return On Assets Ratios
CNTB's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CNTB's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CNTB's Competitors
Subscribers only: Roa for Connect Biopharma Holdings Limited's Suppliers
Subscribers only: Return On Assets for CNTB's Customers

You may also want to know
CNTB's Roi	CNTB's Inventory Turnover Ratio	CNTB's Growth Rates	CNTB's Dividend Comparisons
	CNTB's Profitability Ratios	CNTB's Asset Turnover Ratio	CNTB's Dividend Growth
CNTB's Roe	CNTB's Valuation Ratios	CNTB's Financial Strength Ratios	CNTB's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-03T11:39:10+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.